ARYX - ARYx Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-19,7244,1584,739
Cost of Revenue-2322622,116
Gross Profit-19,4923,8962,623
Operating Expenses
Research Development21,04039,83824,99423,973
Selling General and Administrative10,19810,0717,7026,938
Non Recurring----
Total Operating Expenses31,23850,14132,95833,027
Operating Income or Loss-31,238-30,417-28,800-28,288
Income from Continuing Operations
Total Other Income/Expenses Net-1,929-8011,239970
Earnings Before Interest and Taxes-31,238-30,417-28,800-28,288
Interest Expense-2,007-1,928-1,352-1,324
Income Before Tax-33,167-31,218-27,561-27,318
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-33,167-31,218-27,561-27,318
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-33,167-31,218-27,561-27,328
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-33,167-31,218-27,561-27,328